ATMA Submits N500 MDMA Phase II Trial Application To Health Canada

ATMA Journey Centres Inc. (ATMA), Canada's leading psychedelic-assisted therapy training provider, announced that it has submitted to Health Canada a N500 3,4-Methylenedioxymethamphetamine (MDMA) phase II Clinical Trial Application (CTA), which...

Lord's The Hygiene India Launches #THIMovement Campaign to Promote India's Health Hygiene Culture

Lord’s Mark Industries, a prominent diversified business group, has launched The Hygiene India platform to promote holistic hygiene and health culture throughout India. The platform's objective is to become the country's largest health and hygiene...

AstraZeneca Highlights New Data Across Its Vaccines & Immune Therapies Portfolio At ECCMID

At the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), 15 - 18 April 2023, AstraZeneca will highlight new data across its vaccines and immune therapies portfolio, reinforcing its ambition to provide long-lasting...

Merck & Co To Acquire Prometheus Biosciences For Nearly $11 Billion

The corporation will pay $200 per share for Prometheus Biosciences through one of its subsidiaries. Merck & Co has agreed to buy Prometheus Biosciences Inc for roughly $10.8 billion to expand its immunological business, the firms announced...

Pragmatic lung study a streamlined model For Future cancer Clinical Trials commences enrolling pateints

As a component of the National Institutes of Health (NIH), the National Cancer Institute (NCI) has assisted in the beginning of a phase 3 randomised clinical trial (NCT05633602) evaluating a two-drug combination for the treatment of patients with...

ProBioGen Partners With ImmunOs Therapeutics To Deliver Innovative Therapy For Cancer Patients

The agreement between ProBioGen and ImmunOs Therapeutics has been extended in order to continue producing clinical materials on a wide scale for IOS-1002, ImmunOs' main initiative for the treatment of cancer. For the novel biologic created by...

Fibe Collaborates with Pristyn Care To Power Affordable Quality Healthcare Across India

To offer medical expense loans of up to Rs. 10 lacs for all elective treatments on free EMI under their CareNow PayLater proposition, Fibe (previously EarlySalary), one of India's top consumer lending platforms, has partnered with Pristyn Care...

Upsher-Smith Widens Ophthalmic Portfolio With Launch of Brimonidine Tartrate And Timolol Maleate Opthalmic Solution

The AB-rated generic version of the trademarked product Combigan, Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, was just released, according to Upsher-Smith Laboratories, LLC (Upsher-Smith). A collaborative cooperation...

Illumina Partners With Henry Ford Health To Study Impact Of Comprehensive Genomic Testing For Cardiovascular Patients

Henry Ford Health, a not-for-profit healthcare organisation in the Detroit metro region, and Illumina Inc., a world leader in DNA sequencing and array-based technologies, have announced the beginning of a cooperation to examine the effects of...

Importance of Regulatory Affairs In Medical Device Industry

Medical devices are playing a key role in the healthcare ecosystem and provide innovative solutions for improvement of the patient health conditions.

© 2024 India Pharma Outlook. All Rights Reserved.